Services
Company
Legal and Governance
Publication Library / Publications
Evolution of facial aesthetic treatment over five or more years: A retrospective cross-sectional analysis of continuous OnabotulinumtoxinA treatment
Background
Little information exists on how facial aesthetic treatments are incorporated into aesthetic regimens.
Objective
Assess the evolution of facial aesthetic treatments in patients receiving long-term continuous onabotulinumtoxinA treatment.
Methods
This international retrospective chart review included patients with ≥5 years of continuous onabotulinumtoxinA treatments including ≥1 glabellar lines treatment/year. Charts were reviewed for facial areas treated, number of treatments, doses/treatment visit, concomitant aesthetic procedures, and onabotulinumtoxinA-related adverse events.
Results
Data were collected from 5,112 onabotulinumtoxinA treatment sessions for 194 patients over an average of 9.1 years. Dosing was relatively stable over time; however, interinjection intervals increased. Glabellar lines’ treatment temporally preceded crow’s feet lines and forehead lines’ treatment. A majority of patients (85%) also received treatment with fillers. Cumulative increases in onabotulinumtoxinA treatments occurred over time and by facial area corresponding with increases in treatments with injectable fillers, energy-based devices, and prescription topical creams. The longer the patients were treated, the younger they perceived themselves to look. Rates of adverse events were low.
Conclusions
OnabotulinumtoxinA treatment evolved over time, coinciding with growth of the facial aesthetics market. Additional treatment modalities were added as complements to onabotulinumtoxinA. Long-term continuous onabotulinumtoxinA injections are an important component of contemporary facial aesthetic treatment regimens.
Authors
A Carruthers, N Sadick, F Brandt, A Regina T de Almeida, S Fagien, G J Goodman, H Raspaldo, K Smith, S Darmody, C J Gallagher, J Street, L Romagnano
Journal
Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
Therapeutic Area
Dermatology
Center of Excellence
Real-world Evidence & Data Analytics
Year
2015
Read full article